{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:16Z","timestamp":1787067556611,"version":"build-2736575974"},"reference-count":162,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Pemphigoid diseases (PD) are autoimmune skin blistering diseases characterized by autoantibodies directed against proteins of the cutaneous basement membrane zone (BMZ). One of the major antigens is type XVII collagen (BP180), a transmembrane glycoprotein, which is targeted in four PDs: bullous pemphigoid, mucous membrane pemphigoid, linear IgA dermatosis, and pemphigoid gestationis. To date, different epitopes on BP180 have been described to be recognized by PD disease patients\u2019 autoantibodies. Different BP180 epitopes were associated with distinct clinical phenotypes while the underlying mechanisms are not yet fully understood. So far, the main effects of anti-BP180 reactivity are mediated by Fc\u03b3-receptors on immune cells. More precisely, the autoantibody\u2013antigen interaction leads to activation of complement at the BMZ and infiltration of immune cells into the upper dermis and, by the release of specific enzymes and reactive oxygen species, to the degradation of BP180 and other BMZ components, finally manifesting as blisters and erosions. On the other hand, inflammatory responses independent of Fc\u03b3-receptors have also been reported, including the release of proinflammatory cytokines and internalization and depletion of BP180. Autoantibodies against BP180 can also be found in patients with neurological diseases. The assumption that the clinical expression of PD depends on epitope specificity in addition to target antigens, autoantibody isotypes, and antibody glycosylation is supported by the observation that epitopes of PD patients differ from those of PD patients. The aim of the present review is to describe the fine specificities of anti-BP180 autoantibodies in different PDs and highlight the associated clinical differences. Furthermore, the direct effects after binding of the autoantibodies to their target are summarized.<\/jats:p>","DOI":"10.3389\/fimmu.2022.948108","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T10:40:46Z","timestamp":1660128046000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Type XVII collagen: Relevance of distinct epitopes, complement-independent effects, and association with neurological disorders in pemphigoid disorders"],"prefix":"10.3389","volume":"13","author":[{"given":"Bianca","family":"Opelka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Goletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13446","article-title":"Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases","volume":"26","author":"Goletz","year":"2017","journal-title":"Exp Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00546.x","article-title":"Structure and function of hemidesmosomes: More than simple adhesion complexes","volume":"112","author":"Borradori","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2018.04.001","article-title":"Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone","volume":"71","author":"Has","year":"2018","journal-title":"Matrix Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.241794","article-title":"Atypical basement membranes and basement membrane diversity - what is normal anyway","volume":"133","author":"Pastor-Pareja","year":"2020","journal-title":"J Cell Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/1523-1747.ep12598050","article-title":"The epidermal-dermal junction","volume":"65","author":"Briggaman","year":"1975","journal-title":"J Invest Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2017.02.006","article-title":"Basement membranes","volume":"27","author":"Jayadev","year":"2017","journal-title":"Curr Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-014-2061-z","article-title":"Molecular architecture and function of the hemidesmosome","volume":"360","author":"Walko","year":"2015","journal-title":"Cell Tissue Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.103.4.1577","article-title":"Type VII collagen is a major structural component of anchoring fibrils","volume":"103","author":"Sakai","year":"1986","journal-title":"J Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-0436.1990.tb00475.x","article-title":"The hemidesmosomal plaque. i. characterization of a major constituent protein as a differentiation marker for certain forms of epithelia","volume":"45","author":"Owaribe","year":"1990","journal-title":"Differentiation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(93)90940-Q","article-title":"Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain","volume":"151","author":"Giudice","year":"1993","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12616580","article-title":"Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180","volume":"99","author":"Giudice","year":"1992","journal-title":"J Invest Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.07.006","article-title":"Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: A systematic review and meta-analysis","volume":"12","author":"Tampoia","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2021.0136","article-title":"Bullous autoimmune dermatoses","volume":"118","author":"van Beek","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13637","article-title":"Diagnosis of autoimmune bullous diseases","volume":"16","author":"van Beek","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"key":"B18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. bullous diseases French study group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Incidence of bullous pemphigoid and pemphigus in Switzerland: A 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in Male and very old patients: A population-based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12026-017-8975-2","article-title":"Subepidermal autoimmune bullous diseases: Overview, epidemiology, and associations","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17107","article-title":"Incidence of pemphigoid diseases in northern Germany in 2016 - first data from the schleswig-Holstein registry of autoimmune bullous diseases","volume":"35","author":"van Beek","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/bjd.19022","article-title":"Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: A population-based cohort study","volume":"184","author":"Persson","year":"2021","journal-title":"Br J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-017-1778-4","article-title":"Incidence of bullous pemphigoid in Sweden 2005-2012: A nationwide population-based cohort study of 3761 patients","volume":"309","author":"Thorslund","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100004","DOI":"10.1016\/j.xjidi.2021.100004","article-title":"Epidemiology of pemphigus","volume":"1","author":"Kridin","year":"2021","journal-title":"JID Innov"},{"key":"B26","doi-asserted-by":"publisher","first-page":"103036","DOI":"10.1016\/j.autrev.2022.103036","article-title":"Mucous membrane pemphigoid","volume":"21","author":"Du","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2008.06976.x","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in lower franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02292.x","article-title":"Spectrum of autoimmune bullous diseases in Kuwait","volume":"43","author":"Nanda","year":"2004","journal-title":"Int J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04919.x","article-title":"Spectrum of subepidermal immunobullous disorders seen at the national skin centre, Singapore: A 2-year review","volume":"147","author":"Wong","year":"2002","journal-title":"Br J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11108.x","article-title":"Clinical presentation and diagnostic delay in bullous pemphigoid: A prospective nationwide cohort","volume":"167","author":"della Torre","year":"2012","journal-title":"Br J Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaad.2017.10.035","article-title":"Nonbullous pemphigoid: A systematic review","volume":"78","author":"Lamberts","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.03.010","article-title":"Clinical features and practical diagnosis of bullous pemphigoid","volume":"29","author":"Schmidt","year":"2011","journal-title":"Dermatol Clin"},{"key":"B33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13023-014-0136-2","article-title":"Gestational pemphigoid","volume":"9","author":"Huilaja","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B34","article-title":"Linear IgA disease","volume-title":"Diseases of the oral mucosa","author":"Koszory","year":"2022"},{"key":"B35","article-title":"Mucous membrane pemphigoid","volume-title":"Diseases of the oral mucosa","author":"Lamberts","year":"2022"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/jdv.17397","article-title":"European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European academy of dermatology and venereology - part I","volume":"35","author":"Rashid","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/jdv.17395","article-title":"European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European academy of dermatology and venereology - part ii","volume":"35","author":"Schmidt","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2007.08.008","article-title":"Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid","volume":"49","author":"Ishiura","year":"2008","journal-title":"J Dermatol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0625.2001.100405.x","article-title":"Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with c-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule","volume":"10","author":"Hamada","year":"2001","journal-title":"Exp Dermatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10820.x","article-title":"Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid","volume":"166","author":"Blocker","year":"2012","journal-title":"Br J Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2003.12.007","article-title":"Development of an ELISA for the detection of autoantibodies to BP230","volume":"111","author":"Kromminga","year":"2004","journal-title":"Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.22603.x","article-title":"BP230- and BP180-specific auto-antibodies in bullous pemphigoid","volume":"122","author":"Thoma-Uszynski","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1749-6632.2009.04630.x","article-title":"Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid","volume":"1173","author":"Tampoia","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.23","article-title":"Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: A retrospective study of 138 patients","volume":"147","author":"Charneux","year":"2011","journal-title":"Arch Dermatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2010.01080.x","article-title":"IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis","volume":"19","author":"Horvath","year":"2010","journal-title":"Exp Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-018-1817-9","article-title":"BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid","volume":"310","author":"Daneshpazhooh","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01752","article-title":"BP180 is critical in the autoimmunity of bullous pemphigoid","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.23.13739","article-title":"Demonstration of the molecular shape of BP180, a 180-kDa bullous pemphigoid antigen and its potential for trimer formation","volume":"271","author":"Hirako","year":"1996","journal-title":"J Biol Chem"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02396.x","article-title":"Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and c-terminal domains of the 180 kDa BP antigen (BP180): Immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins","volume":"139","author":"Nakatani","year":"1998","journal-title":"Br J Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0923-1811(97)00067-4","article-title":"Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid","volume":"17","author":"Murakami","year":"1998","journal-title":"J Dermatol Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00501.x","article-title":"IgA antibodies of cicatricial pemphigoid sera specifically react with c-terminus of BP180","volume":"112","author":"Nie","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01246.x","article-title":"IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain","volume":"116","author":"Egan","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64772-4","article-title":"The shed ectodomain of collagen XVII\/BP180 is targeted by autoantibodies in different blistering skin diseases","volume":"156","author":"Schumann","year":"2000","journal-title":"Am J Pathol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00497.x","article-title":"IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180","volume":"112","author":"Perriard","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050392","article-title":"BP180\/type XVII collagen: Its role in acquired and inherited disorders or the dermal-epidermal junction","volume":"291","author":"Zillikens","year":"1999","journal-title":"Arch Dermatol Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)52948-3","article-title":"Cloning of type XVII collagen. complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5'-end of the gene and the 3'-untranslated region of the mRNA","volume":"268","author":"Li","year":"1993","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","article-title":"Epidermolysis bullosa","volume":"6","author":"Bardhan","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12338088","article-title":"A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12337492","article-title":"Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103986","article-title":"IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in bullous pemphigoid: Serum levels of these immunoglobulins reflect disease activity","volume":"42","author":"Dopp","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2007.00592.x","article-title":"Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies","volume":"16","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0923-1811(01)00144-X","article-title":"Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain","volume":"28","author":"Kromminga","year":"2002","journal-title":"J Dermatol Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2016.1123092","article-title":"IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases","volume":"12","author":"van Beek","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity","volume":"153","author":"van Beek","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid","volume":"177","author":"Hashimoto","year":"2017","journal-title":"Br J Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13374","article-title":"Clinical and immunological profiles of 25 patients with pemphigoid gestationis","volume":"172","author":"Tani","year":"2015","journal-title":"Br J Dermatol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.09.030","article-title":"Sensitivity and specificity of BP180 NC16A enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis","volume":"76","author":"Al Saif","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2460","article-title":"Value of BIOCHIP technology in the serological diagnosis of pemphigoid gestationis","volume":"97","author":"Sadik","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700594","article-title":"The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies","volume":"127","author":"Di Zenzo","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000115506.76104.ad","article-title":"Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis","volume":"103","author":"Sitaru","year":"2004","journal-title":"Obstet Gynecol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2013.12.402","article-title":"Diagnosis of oral mucous membrane pemphigoid by means of combined serologic testing","volume":"117","author":"Hayakawa","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14351","article-title":"Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid","volume":"174","author":"Ali","year":"2016","journal-title":"Br J Dermatol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00808.x","article-title":"Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801","volume":"113","author":"Zillikens","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15232","article-title":"A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence","volume":"177","author":"Ohata","year":"2017","journal-title":"Br J Dermatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001524","article-title":"Ectodomain shedding generates neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid","volume":"185","author":"Nishie","year":"2010","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jdermsci.2014.07.008","article-title":"Major cleavage-dependent epitopes for linear IgA bullous dermatosis are formed at the boundary between the non-collagenous 16A and collagenous 15 domains of BP180","volume":"76","author":"Yamauchi","year":"2014","journal-title":"J Dermatol Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.034090","article-title":"Shedding of collagen XVII\/BP180 in skin depends on both ADAM10 and ADAM9","volume":"284","author":"Franzke","year":"2009","journal-title":"J Biol Chem"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12345782","article-title":"LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells","volume":"106","author":"Marinkovich","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"adv00054","DOI":"10.2340\/00015555-3399","article-title":"Collagen XVII processing and blistering skin diseases","volume":"100","author":"Nishie","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00129.x","article-title":"The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, Bpag2","volume":"110","author":"Zone","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/jaut.2000.0437","article-title":"Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180","volume":"15","author":"Kromminga","year":"2000","journal-title":"J Autoimmun"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s004030000205","article-title":"Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease","volume":"293","author":"Georgi","year":"2001","journal-title":"Arch Dermatol Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06998.x","article-title":"Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: The pathogenic relevance to HLA class II alleles and disease severity","volume":"154","author":"Oyama","year":"2006","journal-title":"Br J Dermatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202X.2003.22126.x","article-title":"Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients","volume":"122","author":"Di Zenzo","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jaad.2012.09.012","article-title":"Missing the target: Characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay","volume":"68","author":"Fairley","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23853.x","article-title":"Mapping the binding sites of anti-BP180 immunoglobulin e autoantibodies in bullous pemphigoid","volume":"125","author":"Fairley","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16260","article-title":"Super-resolution imaging detects BP180 autoantigen in immunoglobulin m pemphigoid","volume":"49","author":"Hirano","year":"2022","journal-title":"J Dermatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.017","article-title":"Immunoglobulin m pemphigoid","volume":"85","author":"Boch","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01238","article-title":"Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid","volume":"10","author":"Tasanen","year":"2019","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2352","article-title":"Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: Estimating the risk of the new agents and characterizing the patients","volume":"154","author":"Kridin","year":"2018","journal-title":"JAMA Dermatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14228","article-title":"The role of dipeptidyl peptidase-4 in cutaneous disease","volume":"30","author":"Patel","year":"2021","journal-title":"Exp Dermatol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.11.023","article-title":"HLA-DQB1*03:01 as a biomarker for genetic susceptibility to bullous pemphigoid induced by DPP-4 inhibitors","volume":"138","author":"Ujiie","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12329728","article-title":"Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain","volume":"106","author":"Balding","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0923-1811(03)00035-5","article-title":"Cicatricial pemphigoid sera specifically react with the most c-terminal portion of BP180","volume":"32","author":"Lee","year":"2003","journal-title":"J Dermatol Sci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03598.x","article-title":"The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis","volume":"143","author":"Roh","year":"2000","journal-title":"Br J Dermatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"adv00070","DOI":"10.2340\/00015555-3415","article-title":"Autoantibody profile of a cohort of 54 Italian patients with linear IgA bullous dermatosis: LAD-1 denoted as a major auto-antigen of the lamina lucida subtype","volume":"100","author":"Cozzani","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08858.x","article-title":"IgE autoantibodies against the intracellular domain of BP180","volume":"160","author":"Dresow","year":"2009","journal-title":"Br J Dermatol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04130.x","article-title":"Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses","volume":"144","author":"Laffitte","year":"2001","journal-title":"Br J Dermatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2016.108","article-title":"Macropinocytosis of type XVII collagen induced by bullous pemphigoid IgG is regulated via protein kinase c","volume":"96","author":"Iwata","year":"2016","journal-title":"Lab Invest"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jid.2020.08.031","article-title":"Autoantibodies to BPAG1e trigger experimental bullous pemphigoid in mice","volume":"141","author":"Makita","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02168.x","article-title":"Mucous membrane pemphigoid: A dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease","volume":"138","author":"Setterfield","year":"1998","journal-title":"Br J Dermatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117826","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J Clin Invest"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119639","article-title":"A major role for neutrophils in experimental bullous pemphigoid","volume":"100","author":"Liu","year":"1997","journal-title":"J Clin Invest"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.7.3987","article-title":"Macrophages, but not T and b lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: Macrophage-mediated neutrophil infiltration depends on mast cell activation","volume":"169","author":"Chen","year":"2002","journal-title":"J Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1600-0625.2009.00948.x","article-title":"Animal models for autoimmune bullous dermatoses","volume":"19","author":"Bieber","year":"2010","journal-title":"Exp Dermatol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2249.2004.02401.x","article-title":"Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes","volume":"135","author":"Schmidt","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.5.3461","article-title":"Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice","volume":"177","author":"Sitaru","year":"2006","journal-title":"J Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00488","article-title":"Tissue destruction in bullous pemphigoid can be complement independent and may be mitigated by C5ar2","volume":"9","author":"Karsten","year":"2018","journal-title":"Front Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.03.037","article-title":"Experimental laminin 332 mucous membrane pemphigoid critically involves C5aR1 and reflects clinical and immunopathological characteristics of the human disease","volume":"137","author":"Heppe","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13367","article-title":"Complement-independent blistering mechanisms in bullous pemphigoid","volume":"26","author":"Iwata","year":"2017","journal-title":"Exp Dermatol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001753","article-title":"FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid","volume":"187","author":"Messingham","year":"2011","journal-title":"J Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.11.029","article-title":"Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway","volume":"182","author":"Hiroyasu","year":"2013","journal-title":"Am J Pathol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.305","article-title":"IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (Type XVII collagen) and weakens cell attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41374-018-0113-9","article-title":"The direct binding of collagen XVII and collagen IV is disrupted by pemphigoid autoantibodies","volume":"99","author":"Kamaguchi","year":"2019","journal-title":"Lab Invest"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/BF02507102","article-title":"Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid","volume":"288","author":"Schmidt","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(97)00044-3","article-title":"Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid","volume":"16","author":"Inaoki","year":"1998","journal-title":"J Dermatol Sci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00141.x","article-title":"Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes","volume":"115","author":"Schmidt","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01503.x","article-title":"The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone","volume":"124","author":"Schmidt","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14097","article-title":"S2k guidelines for the treatment of pemphigus Vulgaris\/Foliaceus and bullous pemphigoid: 2019 update","volume":"18","author":"Schmidt","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15649","article-title":"An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone","volume":"177","author":"Sticherling","year":"2017","journal-title":"Br J Dermatol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30560-3","article-title":"Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: A pragmatic, non-inferiority, randomised controlled trial","volume":"389","author":"Williams","year":"2017","journal-title":"Lancet"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2012.01529.x","article-title":"Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8","volume":"21","author":"Van den Bergh","year":"2012","journal-title":"Exp Dermatol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: A prospective case-control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10386.x","article-title":"Comorbidity profiles among patients with bullous pemphigoid: A nationwide population-based study","volume":"165","author":"Chen","year":"2011","journal-title":"Br J Dermatol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: A population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510369146","article-title":"Autoimmune diseases prior to the diagnosis of multiple sclerosis: A population-based case-control study","volume":"16","author":"Langer-Gould","year":"2010","journal-title":"Mult Scler"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1080\/00015550410024481","article-title":"A retrospective epidemiological study on the association of bullous pemphigoid and neurological diseases","volume":"85","author":"Stinco","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-181191","article-title":"Neurodegenerative disease-related proteins within the epidermal layer of the human skin","volume":"69","author":"Akerman","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2012.00005","article-title":"Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis","volume":"3","author":"Clos","year":"2012","journal-title":"Front Neurol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"37125","DOI":"10.1212\/WNL.0b013e3182941990","article-title":"Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish care register study","volume":"6","author":"Forsti","year":"2016","journal-title":"Sci Rep"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182941990","article-title":"Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk","volume":"80","author":"White","year":"2013","journal-title":"Neurology"},{"key":"B138","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/cne.20549","article-title":"Collagen XVII and BPAG1 expression in the retina: Evidence for an anchoring complex in the central nervous system","volume":"487","author":"Claudepierre","year":"2005","journal-title":"J Comp Neurol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2007.04.073","article-title":"Distribution of collagen XVII in the human brain","volume":"1158","author":"Seppanen","year":"2007","journal-title":"Brain Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1159\/000315393","article-title":"Sera of elderly bullous pemphigoid patients with associated neurological diseases recognize bullous pemphigoid antigens in the human brain","volume":"57","author":"Chen","year":"2011","journal-title":"Gerontology"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2005.11.004","article-title":"Collagen XVII is expressed in human CNS neurons","volume":"25","author":"Seppanen","year":"2006","journal-title":"Matrix Biol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.322","article-title":"The association of bullous pemphigoid with cerebrovascular disease and dementia: A case-control study","volume":"146","author":"Taghipour","year":"2010","journal-title":"Arch Dermatol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13401","article-title":"Neurological and psychiatric associations in bullous pemphigoid-more than skin deep","volume":"26","author":"Forsti","year":"2017","journal-title":"Exp Dermatol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17465","article-title":"The burden of neurological comorbidities in six autoimmune bullous diseases: A population-based study","volume":"35","author":"Kridin","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B145","article-title":"Bullous pemphigoid in a leg affected with hemiparesia: A possible relation of neurological diseases with bullous pemphigoid","volume":"11","author":"Foureur","year":"2001","journal-title":"Eur J Dermatol"},{"key":"B146","article-title":"The association between bullous pemphigoid and neurological disorders in a selected Malaysian population","volume":"70","author":"Kwan","year":"2015","journal-title":"Med J Malaysia"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.adengl.2014.09.010","article-title":"Association between bullous pemphigoid and neurologic diseases: A case-control study","volume":"105","author":"Casas-de-la-Asuncion","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20142516","article-title":"Bullous pemphigoid and comorbidities: A case-control study in Portuguese patients","volume":"89","author":"Teixeira","year":"2014","journal-title":"Bras Dermatol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.07.052","article-title":"A population-based study of the association between bullous pemphigoid and neurologic disorders","volume":"71","author":"Brick","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1684\/ejd.2010.0805","article-title":"Bullous pemphigoid and internal diseases - a case-control study","volume":"20","author":"Jedlickova","year":"2010","journal-title":"Eur J Dermatol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.2994","article-title":"Mortality of bullous pemphigoid in China","volume":"149","author":"Li","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15405","article-title":"Increased frequency of multiple sclerosis among patients with bullous pemphigoid: A population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid","volume":"176","author":"Kibsgaard","year":"2017","journal-title":"Br J Dermatol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.191132","article-title":"Neurological diseases and bullous pemphigoid: A case-control study in Iranian patients","volume":"83","author":"Daneshpazhooh","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10654-013-9866-z","article-title":"The Rotterdam study: 2014 objectives and design update","volume":"28","author":"Hofman","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"B156","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000492820","article-title":"Impact of the ageing population on the burden of stroke: The Dijon stroke registry","volume":"52","author":"Bejot","year":"2019","journal-title":"Neuroepidemiology"},{"key":"B157","doi-asserted-by":"publisher","first-page":"240570","DOI":"10.1155\/2013\/240570","article-title":"Collagen XVII: A shared antigen in neurodermatological interactions","volume":"2013","author":"Seppanen","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1159\/000495813","article-title":"Ageing population: A neurological challenge","volume":"52","author":"Bejot","year":"2019","journal-title":"Neuroepidemiology"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.09.010","article-title":"Increased levels of the bullous pemphigoid BP180 autoantibody are associated with more severe dementia in alzheimer's disease","volume":"137","author":"Kokkonen","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"107","DOI":"10.21037\/atm-20-5343","article-title":"Analysis of the autoimmune response against BP180 in patients with alzheimer's disease","volume":"9","author":"Wang","year":"2021","journal-title":"Ann Transl Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14538","article-title":"Parkinson Disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction","volume":"175","author":"Recke","year":"2016","journal-title":"Br J Dermatol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.09.010","article-title":"BP180 autoantibodies target different epitopes in multiple sclerosis or alzheimer's disease than in bullous pemphigoid","volume":"139","author":"Tuusa","year":"2019","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.948108\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T10:41:03Z","timestamp":1660128063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.948108\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":162,"alternative-id":["10.3389\/fimmu.2022.948108"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.948108","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"article-number":"948108"}}